3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Arthritis, Rheumatoid
2
Cardiovascular Diseases
1
Interventions
Adalimumab
13
Etanercept
8
Methotrexate
7
Rituximab
6
Abatacept
6
tocilizumab
5
golimumab
5
tofacitinib
4
olokizumab
4
Certolizumab Pegol
4
Tumor Necrosis Factor Inhibitors
3
Infliximab
3
Saline Solution
2
Antirheumatic Agents
2
upadacitinib
1
secukinumab
1
sarilumab
1
mavrilimumab
1
baricitinib
1
Vitamin D
1
Vaccines
1
TACI receptor-IgG Fc fragment fusion protein
1
Syringes
1
Sulfasalazine
1
Sodium Chloride
1
Radioimmunodetection
1
RC-18
1
Pharmaceutical Preparations
1
Lysine Acetyltransferase 5
1
Leflunomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Arthritis, Rheumatoid
×
Antirheumatic Agents
×
Clear all
NCT01548768
2020-11-27
RHYTHM
Columbia University
Phase 4
Completed
149 enrolled
15 charts
NCT02046603
2018-12-07
ACT-MOVE
Hoffmann-La Roche
Phase 3
Completed
162 enrolled
30 charts